Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome

American Journal of Medicine

Volumn 103, Issue 3, 1997, Pages 223-232

  Wheat, Joe ^a,b   Mawhinney, Samantha ^c   Hafner, Richard ^d   McKinsey, David ^e   Chen, Dafeng ^c   Korzun, Ann ^c   Shakan, Kenneth J ^f   Johnson, Phillip ^g   Hamill, Richard ^h   Bamberger, David ⁱ   Pappas, Peter ^j   Stansell, John ^k   Koletar, Susan ^l   Squires, Kathleen ^m   Larsen, Robert A ⁿ   Cheung, Tony ^o   Hyslop, Newton ^p   Lai, Kwan Kew ^q   Schneider, Debra ^r   Kauffman, Carol ^s   Saag, Michael ^j   Dismukes, William ^j   Powderly, William ^t   more..

^a INDIANA UNIVERSITY   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SDAC AIDS Clinical Trials Group   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Infectious Disease Associates of Kansas City   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k SAN FRANCISCO GENERAL HOSPITAL   (United States)

^l OHIO STATE UNIVERSITY   (United States)

^m Department of Obstetrics Gynecology   (United States)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p TULANE UNIVERSITY   (United States)

^q UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^r FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^s VETERANS AFFAIRS MEDICAL CENTER   (United States)

^t WASHINGTON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER METABOLISM; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; DISEASE-FREE SURVIVAL; FEMALE; FLUCONAZOLE; HISTOPLASMOSIS; HUMANS; MALE; PATIENT SELECTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0030799906     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00151-4     Document Type: Article

References (19)

1. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine, 69:1990;361-374.
2. Wheat J, Hafner R, Korzun AH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med. 98:1995;336-342.
3. McKinsey DS, Gupta MR, Riddler SA, et al. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Ann Intern Med. 111:1989;655-659.
4. McKinsey DS, Gupta MR, Driks M, Smith DL, O'Connor M. Kansas City AIDS Research Consortium. Histoplasmosis in patients with AIDS: efficacy of maintenance amphotericin B therapy. Am J Med. 92:1992;225-227.
5. Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 118:1993;610-616.
6. Norris S, Wheat J, McKinsey D, et al. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med. 96:1994;504-508.
7. Stein AG, Daneshmend TK, Warnock DW, et al. The effects of H2-receptor antagonists on the pharmacokinetics of itraconazole, a new oral antifungal. Brit J Clin, Pharmacol. 27:1989;105P-106P.
8. Tucker RM, Denning DW, Hanson LH, et al. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis. 14:1992;165-174.
9. Sharkey-Mathis PK, Velez J, Fetchick R, Graybill JR. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole. J Acquir Immune Defic Syndr. 6:1993;809-819.
10. Pottage JC Jr., Sha BE. Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazole. J Infect Dis. 164:1991;622-623.
11. Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med. 314:1986;83-88.
12. Wheat LJ, Connolly-Stringfield P, Blair R, et al. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med. 92:1992;153-160.
13. Fromtling RA, Galgiani JN, Pfaller MA, et al. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother, 37:1993;39-45.
14. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53:1958;457-481.
15. Snedecor GW, Cochran WG. Statiscal Methods. 1980;Iowa State University Press, Ames, Iowa.
16. Kalbfleisch JD, Prentice RL. Introduction. The Statistical Analysis of Failure Time Data. 1980;14-15 John Wiley, New York.
17. McKinsey DS, Kauffman CA, Pappas PG, et al. Fluconazole therapy for histoplasmosis. Clin Infect Dis. 23:1996;996-1001.
18. Wheat J, Marichal P, Vanden Bossche H, et al. Hypothesis on the mechanism of resistance to fluconazole in histoplasma capsulatum. Antimicrob Agents Chemother. 41:1997;410-414.
19. Wheat LJ, Connolly-Stringfield P, Blair R, et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med. 115:1991;936-941.